Plasmid-mediated colistin resistance in Latin America and Caribbean: A systematic review. 2019

Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
Laboratório de Diagnóstico Laboratorial e Microbiologia Clínica. Universidade Federal de São João del-Rei (UFSJ), Campus Centro-Oeste Dona Lindu, Divinópolis, Minas Gerais, Brazil.

A systematic review was performed in order to integrate and synthesize available information on mcr genes dissemination in Latin America. Four databases were searched for articles reporting plasmid-mediated colistin resistance between bacteria isolated from countries of Latin America and the Caribbean. Abstract books of scientific events realized in each region were also examined. After search and selection, 48 studies that included 18,705 isolates recovered between 2000 and 2018 were evaluated. The overall frequency of mcr genes in Latin America was 2.9% (550/18,705), with IncX4 plasmids shown to be the key vectors responsible for the dissemination of genes within the continent. Brazil, Bolivia and Argentina were the countries with the highest number of mcr-positive isolates, and only Colombia (mcr-5) and Brazil (mcr-3) presented mcr genes other than type 1. Escherichia coli, Klebsiella pneumoniae, and Salmonella enterica serovar Typhimurium were mainly found to carry the gene within the continent and these microorganisms showed high susceptibility to ertapenem, meropenem, piperacillin/tazobactam, fosfomycin and tigecycline. This review showed that the mcr gene is circulating in several countries of Latin America. Thus, it is important to encourage microbiological and molecular surveillance programs to avoid the spread of these genes within and outside the continent.

UI MeSH Term Description Entries
D007843 Latin America The geographic area of Mexico, Central America, continent of South America and the islands of the Caribbean where Spanish or other Romance language is spoken.
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D003091 Colistin Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Polymyxin E,Colimycin,Colisticin,Colistin Sulfate,Coly-Mycin,Totazina,Sulfate, Colistin
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D017691 Caribbean Region The area that lies between continental North and South America and comprises the Caribbean Sea, the West Indies, and the adjacent mainland regions of southern Mexico, Central America, Colombia, and Venezuela. West Indies Region,Caribbean,Caribbean Sea Region
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
January 2019, Revista Argentina de microbiologia,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
February 2020, Molecular biology reports,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
December 2017, Journal of the European Academy of Dermatology and Venereology : JEADV,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
August 2019, Expert review of vaccines,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
February 2019, Microorganisms,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
February 2021, Current HIV/AIDS reports,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
July 2021, BMJ open,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
February 2009, Revista panamericana de salud publica = Pan American journal of public health,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
February 2022, Journal of applied microbiology,
Victor Rocha Mendes Oliveira, and Magna Cristina Paiva, and William Gustavo Lima
March 2016, Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999),
Copied contents to your clipboard!